A sensor platform based on ANO1 aptamer nanoconjugates for the visualization detection of circulating tumor cells (CTCs) in peripheral blood

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084096

Enrollment

Unknown

Registered

2024-05-10

Start date

2024-06-12

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

Malignant tumor metastasis group:None

Malignant tumors without metastasis group:None

Healthy people:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) They are between 18 and 80 years old (2)Clinical blood samples from patients with malignant tumors (without symptoms of cancer cell metastasis). (3) Clinical blood samples from patients with malignant tumors (with symptoms of cancer cell metastasis).

Exclusion criteria

Exclusion criteria: (1)No hemolytic specimens are collected

Design outcomes

Primary

Measure	Time frame
Analyzing cellular fluorescence images using laser confocal microscopy.;	—

Secondary

Measure	Time frame
Fluorescence signal was detected by flow cytometry;	—

Countries

China

Contacts

Public ContactFeng Hao

Faculty of jilin medical university

haof863@nenu.edu.cn+86 136 8988 1986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026